Celcuity Inc is active in the healthcare domain. It is a cellular analysis company that is discovering new cancer sub-types and commercialising diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses the patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-06 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.220 | -0.210 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CELC | Celcuity | 50.94% | 265.4M |
Celcuity Company Questions & Answers
Q
How do I buy Celcuity (CELC) stock?
A
You can purchase shares of Celcuity (NASDAQ: CELC) through any online brokerage.
Q
Who are Celcuity's (CELC) main competitors?
A
There are no as such competitors for Celcuity.
Q
What is the target price for Celcuity?
A
The latest price target for Celcuity (NASDAQ: CELC) was reported by HC Wainwright & Co. on 2021-02-17. The analyst firm set a price target for 19.00 expecting CELC to fall to within 12 months (a possible -12.04% downside). 1 analyst firms have reported ratings in the last year.
Q
How much is Celcuity (CELC) stock ?
A
The stock price for Celcuity (NASDAQ: CELC) is $21.6 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Celcuity (CELC) dividend?
A
There are no upcoming dividends for Celcuity.
Q
When is Celcuity (NASDAQ:CELC) reporting earnings?
A
Celcuity’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q
When is the upcoming split for CELC?
A
There is no upcoming split for Celcuity.